November 28, 2018
November 14, 2018
MARKET OUTLOOKThe accelerated approvals of Kymriah (Novartis) for the treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) and Yescarta (Kite…
December 19, 2017
November 22, 2017
November 16, 2017
October 10, 2017
September 22, 2017
September 20, 2017
December 14, 2016